Breaking News Instant updates and real-time market news.

TDOC

Teladoc

$52.51

-1.56 (-2.89%)

16:48
04/16/19
04/16
16:48
04/16/19
16:48

Teladoc initiated with an Overweight at Stephens

Stephens analyst Jacob Johnson initiated Teladoc with an Overweight rating and a price target of $75, saying the company is an "industry leader" in the telehealth industry which is undergoing "considerable growth" that is still in its "early innings". The analyst also notes that any M&A by Teladoc should "increase the value of its platform by adding capabilities and geographies", adding that while its gross margins may decline as a result of a "shifting revenue mix," the company's operating leverage should result in expanding EBITDA margins. Johnson further states that Teladoc shares are not cheap, but still trade "at a discount to high-growth healthcare and tech peers."

  • 30

    Apr

  • 05

    Jun

TDOC Teladoc
$52.51

-1.56 (-2.89%)

03/28/19
JPMS
03/28/19
NO CHANGE
Target $80
JPMS
Overweight
Teladoc 19% selloff presents buying opportunity, says JPMorgan
JPMorgan analyst Lisa Gill views the 19% pullback since March 21 in shares of Teladoc as a buying opportunity. The analyst does not have a fundamental reason to point to for the selloff and believes the company's underlying fundamentals are unchanged. Gill has heard some concerns following the Forbes article earlier this week that questioned Teladoc's use of an adjusted EBITDA metric. She notes, however, that nearly all of the companies within her coverage universe focus investors on an adjusted EBITDA or adjusted EBIT. With the acquisitions that Teladoc has done over the past few years, amortization has grown significantly, and excluding that helps to better understand the underlying growth of the business, Gill tells investors in a research note. The analyst continues to see "significant runway" in the telehealth space going forward and keeps an Overweight rating on Teladoc with an $80 price target.
04/01/19
PIPR
04/01/19
NO CHANGE
Target $86
PIPR
Overweight
Teladoc oversold on Aetna contract confusion, says Piper Jaffray
Piper Jaffray analyst Sean Wieland believes some confusion over Aetna's intentions have pressured the shares of Teladoc (TDOC). The confusion lies in the fact that this was a "Request for Price" and not a "Request for Proposal," Wieland tells investors in a research note. However, his channel checks indicate there isn't any intention of CVS Health's (CVS) Aetna switching vendors. To the contrary, we've seen companies do this in front of a contract expansion, when they need to provide the board with benchmark pricing data to prove they are not overpaying, says the analyst. As such, he believes potential risk related to Teladoc's Aetna contract is minimal. Further, Wieland sees upside to Teladoc's initial guidance on stronger utilization trends as "telemedicine continues to go mainstream." He views the stock as oversold and reiterates an Overweight rating with an $86 price target.
04/08/19
PIPR
04/08/19
NO CHANGE
Target $86
PIPR
Overweight
Final CMS rule 'another win' for telemedicine industry, says Piper Jaffray
The Centers for Medicare & Medicaid Services on Friday issued a final that marks "another win" for the telemedicine industry, Piper Jaffray analyst Sean Wieland tell investors in a research note. Beginning 2020, Medicare Advantage plans will cover various telehealth services, including phone/video visits for medical or mental health needs, says the analyst. He believes there is a "strong value proposition" for health plans to promote these services to their beneficiaries, and that Teladoc is well positioned to gain from this trend. Wieland reiterates an Overweight rating on Teladoc shares with an $86 price target.
04/16/19
SPHN
04/16/19
INITIATION
Target $75
SPHN
Overweight
Teladoc initiated with an Overweight at Stephens
Stephens initiated Teladoc with an Overweight and $75 price target.

TODAY'S FREE FLY STORIES

XCEL

EXCEL ENERGY INC.

$0.00

(0.00%)

06:08
04/25/19
04/25
06:08
04/25/19
06:08
Earnings
Excel Energy reports Q1 EPS 61c, consensus 61c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$115.19

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
West Pharmaceutical raises FY19 adj. EPS view to $2.80-$2.90 from $2.77-$2.89 »

Consensus $2.86. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Breaking Earnings news story on Iron Mountain »

Iron Mountain sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Bombardier cuts FY19 revenue view to about $17B, consensus $16.26B »

Consolidated revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

NTB

Butterfield

$37.30

-0.18 (-0.48%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Hot Stocks
Butterfield to acquire ABN AMRO Channel Islands for approximately $208M »

The Bank of N.T.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 30

    Apr

WST

West Pharmaceutical

$115.19

(0.00%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
West Pharmaceutical reports Q1 adj. EPS 74c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ENTG

Entegris

$40.85

0.18 (0.44%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
Entegris sees Q2 non-GAAP EPS 40c-45c, consensus48c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

WCN

Waste Connections

$89.28

0.01 (0.01%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Bombardier sees Q1 revenue about $3.5B, consensus $4.76B »

Revenues for Q1 are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Iron Mountain reports Q1 adj. EPS 17c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

ENTG

Entegris

$40.85

0.18 (0.44%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Recommendations
Entegris analyst commentary  »

Entegris reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

PTEN

Patterson-UTI

$15.13

-0.71 (-4.48%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Earnings
Patterson-UTI reports Q1 EPS (14c), consensus (21c) »

Reports Q1 revenue $704M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

TER

Teradyne

$47.99

3.39 (7.60%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Teradyne rating change  »

Teradyne upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 29

    May

VMI

Valmont

$132.99

1.845 (1.41%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Valmont rating change  »

Valmont upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 24

    Jul

DHI

D.R. Horton

$46.67

0.275 (0.59%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
D.R. Horton sees FY19 homes closed 55,000-56,000 »

Sees FY19: Effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GRA

W.R. Grace

$75.21

-1.225 (-1.60%)

, FTI

TechnipFMC

$24.77

-0.66 (-2.60%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
W.R. Grace and TechnipFMC collaborating in high yield cracking process »

W. R. Grace (GRA) has…

GRA

W.R. Grace

$75.21

-1.225 (-1.60%)

FTI

TechnipFMC

$24.77

-0.66 (-2.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 08

    May

CUI

CUI Global

$1.17

-0.02 (-1.68%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
CUI Global subsidiary secures GasPT orders from Samson »

CUI Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Downgrade
Occidental Petroleum rating change  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 07

    May

  • 10

    May

  • 29

    May

DHI

D.R. Horton

$46.67

0.275 (0.59%)

06:02
04/25/19
04/25
06:02
04/25/19
06:02
Earnings
Breaking Earnings news story on D.R. Horton »

D.R. Horton sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DHI

D.R. Horton

$46.67

0.275 (0.59%)

06:01
04/25/19
04/25
06:01
04/25/19
06:01
Earnings
D.R. Horton reports Q2 EPS 93c, consensus 86c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

06:01
04/25/19
04/25
06:01
04/25/19
06:01
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

GOOG

Alphabet

$1,255.22

-9.27 (-0.73%)

, GOOGL

Alphabet Class A

$1,260.07

-10.53 (-0.83%)

06:01
04/25/19
04/25
06:01
04/25/19
06:01
Hot Stocks
SoftBank subsidiary HAPSMobile invests $125M in Alphabet's Loon »

SoftBank Corp.'s…

GOOG

Alphabet

$1,255.22

-9.27 (-0.73%)

GOOGL

Alphabet Class A

$1,260.07

-10.53 (-0.83%)

SFTBF

SoftBank

$0.00

(0.00%)

AVAV

AeroVironment

$67.99

-0.74 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 29

    Apr

  • 29

    Apr

  • 14

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 27

    Oct

ALLE

Allegion

$95.50

-0.45 (-0.47%)

06:00
04/25/19
04/25
06:00
04/25/19
06:00
Earnings
Allegion backs FY19 adj. EPS $4.75-$4.90, consensus $4.86 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LTXB

LegacyTexas Financial

$38.05

-3.13 (-7.60%)

05:59
04/25/19
04/25
05:59
04/25/19
05:59
Upgrade
LegacyTexas Financial rating change  »

LegacyTexas upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

FB

Facebook

$182.64

-1.13 (-0.61%)

05:59
04/25/19
04/25
05:59
04/25/19
05:59
Recommendations
Facebook analyst commentary at Mizuho »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.